Іздестіру
Supply Control
Reducing the availability of illegal substances through law enforcement and regulation.
A Review of the Quality of Drug Treatment, Sustained Recovery and Related Support Services based on data submitted in the Annual Report Questionnaire collections in 2020 and 2021
In 2021, the Commission on Narcotic Drugs (CND) called on UNODC, alongside Member States and partners, to assess the quality of drug prevention, treatment, sustained recovery, and related support services worldwide. This report uses data...
The Relationship Between Person-Centred Care for Substance Use Disorders and Service Outcomes: a Systematic Scoping Review
This Discussion Paper, prepared by UNODC, aligns with key international policy frameworks, including CND resolutions 59/4 and 64/3. These resolutions highlight the importance of developing and disseminating international standards for the...
The Relationship Between Quality of Specialist Treatment for Substance Use Disorders and Patient Outcomes: A Scoping Review of the Literature
This Discussion Paper, prepared by UNODC, aligns with key international policy frameworks, including Commission on Narcotic Drugs (CND) resolutions 59/4 and 64/3. These resolutions emphasise the development and dissemination of...
Quality Assurance In Treatment For Drug Use Disorders: Key Quality Standards For Service Appraisal
Improving the quality and coverage of treatment for drug use disorders is a global health priority, highlighted in the United Nations Sustainable Development Goals. To support this, the Key Quality Standards for Drug Use Disorder Treatment...
Quality Assurance for Drug Use Disorder Treatment
Over 38 million people worldwide are living with drug use disorders, yet only a fraction have access to appropriate treatment. These disorders place a heavy burden on individuals, families and communities, and their wider social costs –...
International Standards for the Treatment of Drug Use Disorders
The International Standards for the Treatment of Drug Use Disorders, developed by UNODC and WHO, provide guidance for countries to strengthen evidence-based, ethical and effective treatment systems. They are designed for policymakers...
Substance Control Ecosystem
Psychoactive substances are regulated under three key United Nations conventions, agreed by Member States to safeguard public health and prevent illegal drug production:
-
1961 Single Convention on Narcotic Drugs – focused on substances...
UN Toolkit on Synthetic Drugs
The 2024 Feedback Survey gathered valuable insights from users of the UN Toolkit on Synthetic Drugs. Running from January to December 2024, it assessed user experiences, explored how Toolkit resources are applied, and identified areas for...
Multilingual Dictionary of Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances under International Control
Similar to controlled narcotic drugs and psychotropic substances, precursors and chemicals often appear under a wide range of names in commerce and technical literature. This makes the work of national and international drug control...
Toolkit on Stakeholder Engagement: Implementing the United Nations Convention against Transnational Organised Crime (UNTOC)
The UNODC has developed a Toolkit designed to strengthen the capacity of civil society, academia, and the private sector to support the implementation of the UN Convention against Transnational Organised Crime (UNTOC) and its Protocols.
...
World Drug Report 2025: Key Trends and Policy Challenges for Africa
ISSUP Global, UNODC, and the African Union presents their webinar on the World Drug Report 2025, focusing on key trends and policy challenges for Africa.
Establishing Global-Regional Collaboration in Drug Demand and Supply Reduction Programs
The presentation deliver about the establishment of the Global-Regional Collaboration in Drug Demand and Supply Reduction Programs. The 2025 World Drug Report figures paint a sobering picture of our reality. Methamphetamine seizures across East and Southeast Asia, reaching 236 tons in 2024, serves as a stark reminder that we are facing an evolving and increasingly sophisticated enemy.
Release of Global Coalition to Address Synthetic Drug Threats Report
The latest report from the Global Coalition to Address Synthetic Drug Threats highlights the significant progress made since its launch in July 2023.
GISA raises alarm over danger of synthetic drug abuse
Nigeria is facing a growing crisis with synthetic drugs, with stakeholders warning of devastating consequences if urgent actions are not taken.
UNODC World Drug Report 2024: Harms of world drug problem continue to mount amid expansions in drug use and markets
The emergence of new synthetic opioids and a record supply and demand of other drugs has compounded the impacts of the world drug problem, leading to a rise in drug use disorders and environmental harms, according to the World Drug Report 2024 launched by the UN Office on Drugs and Crime (UNODC).
Highlights from the 2024 UNODC World Drug Report
ISSUP is pleased to presents highlights from the 2024 edition of the UNODC World Drug Report. The webinar is presented by Giovanna Campello, Chief of the Prevention, Treatment, and Rehabilitation Section at the United Nations Office on Drugs and Crime (UNODC).
Penalties for drug law offences in Europe at a glance
This resource facilitates the examination and comparison of penalties or rehabilitative measures for primary drug-related offenses such as drug use, possession for personal use, and supply-related crimes across European countries...
New Global Coalition Launched to Address Synthetic Drug Threats
On July 7, 2023, U.S. Secretary of State Antony Blinken hosted a virtual Ministerial-level meeting to launch a Global Coalition to address Synthetic Drug Threats.
World Drug Report 2023
For the first time since its conception, this year the World Drug Report consists of two products, a web-based element and a set of booklets.
Highlights from the 2023 UNODC World Drug Report
ISSUP are pleased to present our Webinar on highlights from the 2023 edition of the UNODC World Drug Report.